Small intestinal bacterial overgrowth syndrome in children with idiopathic nephritic syndrome treated with immunosuppressive agents

Small intestinal bacterial overgrowth syndrome is defined as an increased number of non-pathogenic bacteria over 105 microorganisms in one millilitre of intestinal contents in the initial part of the small intestine. Predisposing disorders include e.g. drug-induced hypochlorydia, congenital and ac...

Full description

Bibliographic Details
Main Authors: Katarzyna Siniewicz-Luzeńczyk, Marcin Tkaczyk
Format: Article
Language:English
Published: Medical Communications Sp. z o.o. 2016-06-01
Series:Pediatria i Medycyna Rodzinna
Subjects:
Online Access:http://www.pimr.pl/index.php/issues/2016-vol-12-no-2/small-intestinal-bacterial-overgrowth-syndrome-in-children-with-idiopathic-nephritic-syndrome-treated-with-immunosuppressive-agents?aid=952
id doaj-726fe5fa80d54d42abda3a5a403cb575
record_format Article
spelling doaj-726fe5fa80d54d42abda3a5a403cb5752020-11-24T22:41:36ZengMedical Communications Sp. z o.o.Pediatria i Medycyna Rodzinna1734-15312451-07422016-06-0112217117610.15557/PiMR.2016.0017Small intestinal bacterial overgrowth syndrome in children with idiopathic nephritic syndrome treated with immunosuppressive agentsKatarzyna Siniewicz-Luzeńczyk0Marcin Tkaczyk1Department of Paediatrics, Immunology and Nephrology, Polish Mother’s Memorial Hospital Research Institute, Łódź, Poland. Head of the Department: Professor Krzysztof Zeman, MD, PhD; The4th Department of Paediatrics, Medical University of Lodz, Łódź, Poland. Head of the Department: Professor Krzysztof Zeman, MD, PhDDepartment of Paediatrics, Immunology and Nephrology, Polish Mother’s Memorial Hospital Research Institute, Łódź, Poland. Head of the Department: Professor Krzysztof Zeman, MD, PhD; The4th Department of Paediatrics, Medical University of Lodz, Łódź, Poland. Head of the Department: Professor Krzysztof Zeman, MD, PhDSmall intestinal bacterial overgrowth syndrome is defined as an increased number of non-pathogenic bacteria over 105 microorganisms in one millilitre of intestinal contents in the initial part of the small intestine. Predisposing disorders include e.g. drug-induced hypochlorydia, congenital and acquired defects of the gastrointestinal tract, immunodeficiency, severe stress situations as well as intestinal microflora imbalance after immunosuppressive therapy. The aim of the study was to assess the incidence of small intestinal bacterial overgrowth in children receiving cyclosporine A due to idiopathic nephritic syndrome. Material and methods: The study included 20 children (11 girls and 9 boys) aged 4–16 years (mean age 8.83 ± 3.75 years), diagnosed with idiopathic nephritic syndrome and treated with cyclosporine for over 3 months. The use of antibiotics or probiotics less than 3 months prior to the study was an exclusion criterion. Serum levels of cyclosporin A were measured in all patients. Hydrogen breath test with lactulose was performed as an additional examination. The exhaled breath was analysed using Gastrolyzer (Bedfont). A minimum increase of 20 hydrogen molecules per million air molecules between the maximum value and the fasting level or values in the first hour of the test was considered as a positive test outcome, indicating small intestinal bacterial overgrowth. Results: Negative result of hydrogen breath test, excluding small intestinal bacterial overgrowth, was observed in all 20 children. Conclusions: The  administration of  second line immunosuppressive agents in children with idiopathic nephritic syndrome does not induce non-pathogenic bacterial multiplication in the small intestine. http://www.pimr.pl/index.php/issues/2016-vol-12-no-2/small-intestinal-bacterial-overgrowth-syndrome-in-children-with-idiopathic-nephritic-syndrome-treated-with-immunosuppressive-agents?aid=952small intestinal bacterial overgrowth syndromeidiopathic nephritic syndromecyclosporine Achildren
collection DOAJ
language English
format Article
sources DOAJ
author Katarzyna Siniewicz-Luzeńczyk
Marcin Tkaczyk
spellingShingle Katarzyna Siniewicz-Luzeńczyk
Marcin Tkaczyk
Small intestinal bacterial overgrowth syndrome in children with idiopathic nephritic syndrome treated with immunosuppressive agents
Pediatria i Medycyna Rodzinna
small intestinal bacterial overgrowth syndrome
idiopathic nephritic syndrome
cyclosporine A
children
author_facet Katarzyna Siniewicz-Luzeńczyk
Marcin Tkaczyk
author_sort Katarzyna Siniewicz-Luzeńczyk
title Small intestinal bacterial overgrowth syndrome in children with idiopathic nephritic syndrome treated with immunosuppressive agents
title_short Small intestinal bacterial overgrowth syndrome in children with idiopathic nephritic syndrome treated with immunosuppressive agents
title_full Small intestinal bacterial overgrowth syndrome in children with idiopathic nephritic syndrome treated with immunosuppressive agents
title_fullStr Small intestinal bacterial overgrowth syndrome in children with idiopathic nephritic syndrome treated with immunosuppressive agents
title_full_unstemmed Small intestinal bacterial overgrowth syndrome in children with idiopathic nephritic syndrome treated with immunosuppressive agents
title_sort small intestinal bacterial overgrowth syndrome in children with idiopathic nephritic syndrome treated with immunosuppressive agents
publisher Medical Communications Sp. z o.o.
series Pediatria i Medycyna Rodzinna
issn 1734-1531
2451-0742
publishDate 2016-06-01
description Small intestinal bacterial overgrowth syndrome is defined as an increased number of non-pathogenic bacteria over 105 microorganisms in one millilitre of intestinal contents in the initial part of the small intestine. Predisposing disorders include e.g. drug-induced hypochlorydia, congenital and acquired defects of the gastrointestinal tract, immunodeficiency, severe stress situations as well as intestinal microflora imbalance after immunosuppressive therapy. The aim of the study was to assess the incidence of small intestinal bacterial overgrowth in children receiving cyclosporine A due to idiopathic nephritic syndrome. Material and methods: The study included 20 children (11 girls and 9 boys) aged 4–16 years (mean age 8.83 ± 3.75 years), diagnosed with idiopathic nephritic syndrome and treated with cyclosporine for over 3 months. The use of antibiotics or probiotics less than 3 months prior to the study was an exclusion criterion. Serum levels of cyclosporin A were measured in all patients. Hydrogen breath test with lactulose was performed as an additional examination. The exhaled breath was analysed using Gastrolyzer (Bedfont). A minimum increase of 20 hydrogen molecules per million air molecules between the maximum value and the fasting level or values in the first hour of the test was considered as a positive test outcome, indicating small intestinal bacterial overgrowth. Results: Negative result of hydrogen breath test, excluding small intestinal bacterial overgrowth, was observed in all 20 children. Conclusions: The  administration of  second line immunosuppressive agents in children with idiopathic nephritic syndrome does not induce non-pathogenic bacterial multiplication in the small intestine.
topic small intestinal bacterial overgrowth syndrome
idiopathic nephritic syndrome
cyclosporine A
children
url http://www.pimr.pl/index.php/issues/2016-vol-12-no-2/small-intestinal-bacterial-overgrowth-syndrome-in-children-with-idiopathic-nephritic-syndrome-treated-with-immunosuppressive-agents?aid=952
work_keys_str_mv AT katarzynasiniewiczluzenczyk smallintestinalbacterialovergrowthsyndromeinchildrenwithidiopathicnephriticsyndrometreatedwithimmunosuppressiveagents
AT marcintkaczyk smallintestinalbacterialovergrowthsyndromeinchildrenwithidiopathicnephriticsyndrometreatedwithimmunosuppressiveagents
_version_ 1725701622146793472